STUDIO LAFFRANCHI DI RADIOLOGIA E TERAPIA FISICA
Studio Medico polispecialistico presente in Como dal 1961

 

RADIOLOGIA:
Pubblicazioni del dr. Alberto Laffranchi

 

  • Villani F, Viola G, Vismara C, Laffranchi A., Di Russo A, Viviani S, Bonfante V.
    Lung function and serum concentrations of different cytokines in patients submitted to radiotherapy and intermediate/high dose chemotherapy for Hodgkin's disease.
    Anticancer Res 2002 Jul-Aug;22(4):2403-8
  • Villani F, Viviani S, Bonfante V, De Maria P, Soncini F, Laffranchi A.
    Late pulmonary effects in favorable stage I and IIA Hodgkin's disease treated with radiotherapy alone.
    Am J Clin Oncol. 2000 Feb;23(1):18-21.
  • Potepan P, Luksch R, Sozzi G, Testi A, Laffranchi A, Danesini GM, Parafioriti A, Giardini R, Spagnoli I.
    Multifocal osteosarcoma as second tumor after childhood retinoblastoma.
    Skeletal Radiol. 1999 Jul;28(7):415-21.
  • Potepan P, Meroni E, Spinelli P, Laffranchi A, Danesini GM, Milella M, Marchesini M, Spagnoli I.
    Non-invasive lymphatic staging of lung neoplasms: comparative study with computerized tomography and endoscopic ultrasonography.
    Radiol Med (Torino). 1999 Jan-Feb;97(1-2):42-7. Italian.
  • Ripamonti C, Fulfaro F, Polastri D, De Conno F, Laffranchi A, Moliterni A.
    Pain relief and sclerosis of bone metastases in a patient with breast cancer treated with tamoxifen, radiotherapy and pamidronate disodium: which treatment helped?
    J Pain Symptom Manage. 1998 Aug;16(2):73-6. No abstract available.
  • Villani F, De Maria P, Bonfante V, Viviani S, Laffranchi A, Dell'oca I, Dirusso A, Zanini M.
    Late pulmonary toxicity after treatment for Hodgkin's disease.
    Anticancer Res. 1997 Nov-Dec;17(6D):4739-42.
  • Ferrari A, Fabietti P, Vessecchia G, Laffranchi A, Lombardi L, Massimino M, Fossati-Bellani F, Giardini R.
    Langerhans cell histiocytosis arising after Hodgkin's disease.
    Pediatr Hematol Oncol. 1997 Nov-Dec;14(6):585-8.
  • Zambetti M, Demicheli R, De Candis D, Antonelli G, Giacobone A, Terenziani M, Laffranchi A, Garbagnati F, Biasi S, Bonadonna G.
    Five-day infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patients.
    Breast Cancer Res Treat. 1997 Jul;44(3):255-60.
  • Potepan P, Tesoro-Tess JD, Laffranchi A, Danesini GM, Gianni C, Uslenghi E, Spagnoli I.
    Langerhans cell histiocytosis mimicking malignancy: a radiological appraisal.
    Tumori. 1996 Nov-Dec;82(6):603-9.
  • Bregni M, Siena S, Di Nicola M, Dodero A, Peccatori F, Ravagnani F, Danesini G, Laffranchi A, Bonadonna G, Gianni AM.
    Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
    J Clin Oncol. 1996 Feb;14(2):628-35.
  • Potepan P, Meroni E, Spagnoli I, Milella M, Danesini GM, Laffranchi A, Civelli E, Alloisio M, Mariani L, Spinelli P, Guzzon A.
    Non-small-cell lung cancer: detection of mediastinal lymph node metastases by endoscopic ultrasound and CT.
    Eur Radiol. 1996;6(1):19-24.
  • Gianni L, Munzone E, Capri G, Fulfaro F, Tarenzi E, Villani F, Spreafico C, Laffranchi A, Caraceni A, Martini C, et al.
    Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.
    J Clin Oncol. 1995 Nov;13(11):2688-99.
  • Zilembo N, Noberasco C, Bajetta E, Martinetti A, Mariani L, Orefice S, Buzzoni R, Di Bartolomeo M, Di Leo A, Laffranchi A, et al.
    Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor.
    Br J Cancer. 1995 Oct;72(4):1007-12.
  • Gianni L, Munzone E, Capri G, Villani F, Spreafico C, Tarenzi E, Fulfaro F, Caraceni A, Martini C, Laffranchi A, et al.
    Paclitaxel in metastatic breast cancer: a trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclines.
    J Natl Cancer Inst. 1995 Aug 2;87(15):1169-75.
  • Zilembo N, Bajetta E, Noberasco C, Buzzoni R, Vicario G, Bono A, Laffranchi A, Biasi G, Dolci S, Bichisao E.
    Formestane: an effective first-line endocrine treatment for advanced breast cancer.
    J Cancer Res Clin Oncol. 1995;121(6):378-82.
  • Zilembo N, Buzzoni R, Celio L, Noberasco C, Ferrari L, Laffranchi A, Vicario G, Dolci S, Bajetta E.
    Formestane as treatment of advanced breast cancer in elderly women.
    Tumori. 1994 Dec 31;80(6):433-7.
  • Potepan P, Spagnoli I, Danesini GM, Laffranchi A, Gadda D, Mascheroni L, Guzzon A.
    The radiodiagnosis of bone metastases from melanoma.
    Radiol Med (Torino). 1994 Jun;87(6):741-6. Italian.
  • Guzzon A, Milani F, Spagnoli I, Danesini GM, Laffranchi A, Potepan P, Giovannardi G, Gattoni F.
    Conventional radiographic follow-up in the irradiated lung.
    Tumori. 1993 Jun 30;79(3):170-82.
  • Guzzon A, Milani F, Spagnoli I, Danesini GM, Laffranchi A, Potepan P, Giovannardi G.
    Radiobiologic and pathologic characteristics of the irradiated lung and roentgenographic aspects.
    Tumori. 1993 Feb 28;79(1):1-8. Review.
  • Potepan P, Danesini GM, Spagnoli I, Laffranchi A, Giovannardi G, Turrini E, Guzzon A.
    Adrenal gland metastasis in osteogenic osteosarcoma. A radiological case report.
    Tumori. 1992 Dec 31;78(6):417-20.
  • Castoldi MC, Danesini GM, Balzarini L, Bergonzi S, Laffranchi A, Guzzon A.
    Current role of conventional tomography in the staging of pulmonary neoplasms. Reflections based on the comparison of tomography-magnetic resonance in 81 cases.
    Radiol Med (Torino). 1991 Oct;82(4):437-42. Italian.